George Dranitsaris (G Dranitsaris)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Neuroendocrine Tumors

Top Venues

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

George Dranitsaris, Heather Neuhalfen, Aaron Peevyhouse, Dakota Powell, Kerri Miller, Teresa Green, Tara Graff
Diagnosis and management of systemic mastocytosis in a community hematology setting. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
George Dranitsaris, Mehdi Moezi, Kate Dobson, Robert Phelan, Sibel Blau
A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nausea and vomiting in cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (8) (2022)
P Ryan, A McBride, D Ray, S Pulgar, R A Ramirez, E Elquza, J P Favaro, George Dranitsaris
Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (6) (2019)
George Dranitsaris, Lesley G Shane, Jean-Philippe Galanaud, Gunar Stemer, Philippe Debourdeau, Seth Woodruff
Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 25 (7) (2017)